%0 Journal Article
%T Exposure Response Supports Therapeutic Drug Monitoring for Dabigatran Etexilate in Patients with Atrial Fibrillation
%A Alesha J. Smith
%A Bryan H. Simpson
%A David M. Reith
%A Natalie J. Medlicott
%J Archive of "TH Open: Companion Journal to Thrombosis and Haemostasis".
%D 2019
%R 10.1055/s-0039-1693486
%X Background £¿Dabigatran etexilate has become widely used for the prevention of stroke in patients with nonvalvular atrial fibrillation (NVAF). Currently, there is limited information in real-world patients relating to dabigatran etexilate exposure and response
%K dabigatran etexilate
%K therapeutic drug monitoring
%K hemorrhage
%K stroke
%K population pharmacokinetic
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639112/